Lung Cancer Survival in Sri Lanka
Open Access
- 9 March 2023
- journal article
- research article
- Published by Georg Thieme Verlag KG in South Asian Journal of Cancer
- Vol. 12 (02), 173-178
- https://doi.org/10.1055/s-0042-1755576
Abstract
Introduction Lung cancer is the second commonest cancer among males in Sri Lanka. Real-world survival data are scarce, and we conducted a retrospective survival analysis among patients treated for lung cancer. Methods All patients with primary lung cancer treated at three selected units during 2015–2016 were included in the study. Data on clinicopathological and treatment delivered were extracted from clinic records. Overall survival was considered the primary end-point. Results The study population comprised 349 patients. The median age was 61 years and majority of patients (74%) were males. Adenocarcinoma (56%) was the commonest histological subtype, followed by squamous cell carcinoma (26%), whereas 6% of patients had small cell lung cancer. Only 10% of patients with non-small cell lung cancer were treated with curative intent, whereas 67% presented with systemic metastases. The median overall survival was 12 months in patients treated with curative intent and there was no significant difference between radical surgery and radiotherapy. The median overall survival was 3 months in those treated palliatively. On multivariate analysis, female gender and first-line treatment with tyrosine kinase inhibitors was associated with superior survival. Conclusion More than 90% of lung cancer patients in Sri Lanka are treated with palliative intent. Further work is needed to identify patient and care pathway barriers to ensure diagnosis at an earlier stage. Conception and design: L.A., V.P., and N.J.; Data collection and analysis: All authors; Manuscript writing: L.A. and N.J.; Manuscript editing: All authors; Manuscript approval: All authors. Data are available on request from the authors. Article published online: 09 March 2023 © 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, IndiaKeywords
This publication has 13 references indexed in Scilit:
- Breast Cancer Survival in Sri LankaJCO Global Oncology, 2020
- Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care centerLung India, 2020
- Clinical Oncology in Sri Lanka: Embracing the Promise of the FutureInternational Journal of Radiation Oncology*Biology*Physics, 2019
- 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort studyThe Lancet Oncology, 2019
- Lung cancer in the Indian subcontinentSouth Asian Journal of Cancer, 2016
- The incidence and mortality of lung cancer and their relationship to development in AsiaTranslational Lung Cancer Research, 2015
- The Global Burden of Cancer 2013JAMA Oncology, 2015
- Clinico-pathological Profile of Lung Cancer at AIIMS: A Changing Paradigm in IndiaAsian Pacific Journal of Cancer Prevention, 2013
- 50-Year Trends in Smoking-Related Mortality in the United StatesThe New England Journal of Medicine, 2013
- Small-cell lung cancerThe Lancet, 2011